As of 2025-07-09, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (8.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.89 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -272.7%.
The range of the Relative Valuation is (8.89) - (8.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 11.4x | 9.1x |
| Forward P/E multiples | 11.8x - 17.2x | 13.4x |
| Fair Price | (8.89) - (8.54) | (8.45) |
| Upside | -281.8% - -274.7% | -272.7% |
| Date | P/E |
| 2025-07-07 | -6.58 |
| 2025-07-03 | -6.62 |
| 2025-07-02 | -6.51 |
| 2025-07-01 | -6.23 |
| 2025-06-30 | -6.29 |
| 2025-06-27 | -6.37 |
| 2025-06-26 | -6.42 |
| 2025-06-25 | -6.14 |
| 2025-06-24 | -5.99 |
| 2025-06-23 | -5.95 |
| 2025-06-20 | -6.01 |
| 2025-06-18 | -6.03 |
| 2025-06-17 | -5.98 |
| 2025-06-16 | -6.10 |
| 2025-06-13 | -6.01 |
| 2025-06-12 | -6.17 |
| 2025-06-11 | -6.10 |
| 2025-06-10 | -6.21 |
| 2025-06-09 | -6.11 |
| 2025-06-06 | -6.14 |
| 2025-06-05 | -5.85 |
| 2025-06-04 | -5.91 |
| 2025-06-03 | -5.85 |
| 2025-06-02 | -5.73 |
| 2025-05-30 | -5.78 |
| 2025-05-29 | -5.85 |
| 2025-05-28 | -5.74 |
| 2025-05-27 | -5.77 |
| 2025-05-23 | -5.77 |
| 2025-05-22 | -5.65 |
| 2025-05-21 | -5.75 |
| 2025-05-20 | -5.91 |
| 2025-05-19 | -5.74 |
| 2025-05-16 | -5.54 |
| 2025-05-15 | -5.23 |
| 2025-05-14 | -5.22 |
| 2025-05-13 | -5.30 |
| 2025-05-12 | -5.37 |
| 2025-05-09 | -5.26 |
| 2025-05-08 | -5.62 |
| 2025-05-07 | -5.83 |
| 2025-05-06 | -5.82 |
| 2025-05-05 | -6.11 |
| 2025-05-02 | -6.09 |
| 2025-05-01 | -5.91 |
| 2025-04-30 | -6.01 |
| 2025-04-29 | -5.90 |
| 2025-04-28 | -5.73 |
| 2025-04-25 | -5.66 |
| 2025-04-24 | -5.74 |